Clinical Trial Update: A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers [NA]

View source ↗

Summary

This update reports an ongoing clinical trial evaluating tumor-treating fields in combination with durvalumab and gemcitabine/cisplatin for biliary tract cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Durvalumab (durvalumab)
• Gemcitabine (Gemcitabine)
• Tumor-Treating Fields (TTFields) therapy (tumor-treating fields)

Snippet

Sponsor: Jiangsu Healthy Life Innovation Medical Technology Co., Ltd | Conditions: Biliary Tract Cancers (BTC) | NA | Status: RECRUITING